Lista de obras -

"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels

artículo científico publicado en 2014

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium

artículo científico publicado en 2003

An Algorithm for the Preclinical Development of Anti-HIV Topical Microbicides ⬇️

artículo científico publicado el 1 de enero de 2012

An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.

artículo científico publicado en 2016

Anti-HSV activity of serpin antithrombin III.

artículo científico publicado en 2014

Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents

artículo científico publicado en 2011

CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants

scientific article published on 12 December 2013

Crystallographic Study of a Novel Subnanomolar Inhibitor Provides Insight on the Binding Interactions of Alkenyldiarylmethanes with Human Immunodeficiency Virus-1 Reverse Transcriptase

artículo científico publicado en 2009

Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors

artículo científico publicado en 2015

Development of Dual-Acting Pyrimidinediones as Novel and Highly Potent Topical Anti-HIV Microbicides ⬇️

artículo científico publicado el 6 de septiembre de 2011

Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection ⬇️

artículo científico publicado el 6 de enero de 2012

Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.

artículo científico publicado en 2008

Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

artículo científico publicado en 2010

Development of topical microbicides to prevent the sexual transmission of HIV

artículo científico publicado en 2009

Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles.

artículo científico publicado en 2011

Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs

artículo científico publicado en 2017

Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1

artículo científico publicado en 2012

Gap junction turnover is achieved by the internalization of small endocytic double-membrane vesicles

artículo científico publicado en 2009

Green-to-red photoconvertible fluorescent proteins: tracking cell and protein dynamics on standard wide-field mercury arc-based microscopes

artículo científico publicado en 2010

Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus

artículo científico publicado en 2015

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

artículo científico publicado en 2014

HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice

scientific article published on 03 January 2014

Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs

artículo científico publicado en 2012

Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database

artículo científico publicado en 2010

In Vitro and Ex Vivo Evaluations on Transdermal Delivery of the HIV Inhibitor IQP-0410 ⬇️

artículo científico publicado el 18 de septiembre de 2013

In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories

artículo científico publicado en 2006

Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef

artículo científico publicado en 2010

Inhibition of tubulin polymerization by select alkenyldiarylmethanes

artículo científico publicado en 2007

Inhibitory Potential of Subpopulations of CD8+T Cells in HIV-1-Infected Elite Suppressors ⬇️

artículo científico publicado el 10 de octubre de 2012

Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors

artículo científico publicado en 2007

Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp

artículo científico publicado en 2005

Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings

artículo científico publicado en 2015

Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication

scientific article published on 23 October 2009

Novel targets for HIV therapy

artículo científico publicado en 2008

Optimization of unique, uncharged thioesters as inhibitors of HIV replication

artículo científico publicado en 2004

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

artículo científico publicado en 2003

Potent inhibition of HIV-1 entry by (s4dU)35.

artículo científico publicado en 2005

Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells

artículo científico publicado en 2013

Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7.

artículo científico publicado en 2017

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy ⬇️

artículo científico publicado el 5 de diciembre de 2011

Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituents

artículo científico publicado en 2006

Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings

artículo científico publicado en 2011

Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention

artículo científico publicado en 2012

Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1

artículo científico publicado en 2003

Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors ⬇️

artículo científico publicado el 1 de mayo de 2003

Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings

artículo científico publicado en 2006

Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems

artículo científico publicado en 2007

Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors

scientific article published on 19 September 2008

Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors

artículo científico publicado en 2005

Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme

artículo científico publicado en 2007

The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets ⬇️

artículo científico publicado el 10 de julio de 2012

The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development

artículo científico publicado en 2015

The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.

artículo científico publicado en 2015

Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy

artículo científico publicado en 2004

Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection ⬇️

artículo científico publicado el 6 de marzo de 2012

Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.

artículo científico publicado en 2011

Lista de obras de

"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium

An Algorithm for the Preclinical Development of Anti-HIV Topical Microbicides ⬇️

An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.

Anti-HSV activity of serpin antithrombin III.

Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents

CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants

Crystallographic Study of a Novel Subnanomolar Inhibitor Provides Insight on the Binding Interactions of Alkenyldiarylmethanes with Human Immunodeficiency Virus-1 Reverse Transcriptase

Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors

Development of Dual-Acting Pyrimidinediones as Novel and Highly Potent Topical Anti-HIV Microbicides ⬇️

Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection ⬇️

Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.

Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Development of topical microbicides to prevent the sexual transmission of HIV

Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles.

Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs

Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1

Gap junction turnover is achieved by the internalization of small endocytic double-membrane vesicles

Green-to-red photoconvertible fluorescent proteins: tracking cell and protein dynamics on standard wide-field mercury arc-based microscopes

Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice

Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs

Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database

In Vitro and Ex Vivo Evaluations on Transdermal Delivery of the HIV Inhibitor IQP-0410 ⬇️

In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories

Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef

Inhibition of tubulin polymerization by select alkenyldiarylmethanes

Inhibitory Potential of Subpopulations of CD8+T Cells in HIV-1-Infected Elite Suppressors ⬇️

Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors

Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp

Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings

Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication

Novel targets for HIV therapy

Optimization of unique, uncharged thioesters as inhibitors of HIV replication

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

Potent inhibition of HIV-1 entry by (s4dU)35.

Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells

Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7.

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy ⬇️

Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituents

Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings

Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention

Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1

Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors ⬇️

Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings

Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems

Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors

Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme

The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets ⬇️

The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development

The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.

Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy

Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection ⬇️

Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.